Skip to main content

Table 2 Differential expression of miRNAs between untreated NMO patients and HCs

From: Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)

Upregulated miRNAs

Downregulated miRNAs

miRNAs NMO vs HCs

Fold change

p value

miRNAs NMO vs HCs

Fold change

p value

hsa-miR-760 (#^)

10.6

0.00021

hsa-miR-7

0.19

0.00034

hsa-miR-423-3p (#)

1.6

0.0008

hsa-miR-140

0.4

0.00042

hsa-miR-660 (#)

6.1

0.00118

hsa-miR-22

0.57

0.00108

hsa-miR-135a (#^)

5.3

0.00202

hsa-miR-143

0.11

0.00109

hsa-miR-135b (#^)

8

0.00329

hsa-miR-150

0.35

0.00126

hsa-miR-1180

2.8

0.00562

hsa-let-7b

0.51

0.00221

hsa-miR-203 (#)

6.5

0.00862

hsa-miR-2110

0.14

0.00541

hsa-miR-18a

1.7

0.01101

hsa-miR-29a

0.28

0.00612

hsa-miR-20b

1.9

0.01591

hsa-miR-342

0.24

0.0103

hsa-miR-100 (#)

2.8

0.02

hsa-miR-10b

0.21

0.01041

hsa-miR-205

6.5

0.0228

hsa-miR-1227

0.12

0.01501

hsa-miR-134 (#^)

4.6

0.02493

hsa-miR-21

0.54

0.01947

hsa-miR-542

6.5

0.03172

hsa-miR-133b

0.16

0.01964

hsa-miR-125b (#^)

1.7

0.0413

hsa-miR-532-5p

0.33

0.02214

hsa-miR-551b

5.7

0.04761

hsa-miR-30e

0.47

0.03266

hsa-miR-454

2.1

0.04839

hsa-miR-133a

0.24

0.03284

hsa-miR-138 (#^)

3.5

0.04892

hsa-miR-139

0.23

0.04032

   

hsa-miR-124

0.33

0.0424

   

hsa-miR-130b

0.44

0.04353

   

hsa-miR-378

0.48

0.0439

   

hsa-miR-215

0.28

0.04642

   

hsa-miR-411

0.19

0.04853

   

hsa-miR-30a

0.32

0.04876

   

hsa-miR-27a

0.46

0.04906

   

hsa-miR-107

0.7

0.05042

  1. miRNAs with increased expression in NMO patients that were normalized following rituximab therapy are indicated by (#); brain-specific/enriched miRNAs are marked with (^)